Startup Drug-Discovery Company BioMotiv Attracts New Millions and a Key Partner
8/13/2013 7:45:59 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Torrey Pines Investment will commit up to $20 million to Cleveland-based biotech accelerator BioMotiv LLC to help fund early stage life sciences companies. The agreement will focus on commercializing research over the next seven years that quickly and cost-effectively can lead to developing new medicines, the companies said. San Diego based Torrey Pines Investment, which has close ties to the Russian and Ukrainian pharmaceutical industries, said it will also lend its contract research and international expertise to the fledgling companies.
Help employers find you! Check out all the jobs and post your resume.